sprodiamide has been researched along with pentetic acid in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.38) | 18.7374 |
1990's | 36 (85.71) | 18.2507 |
2000's | 4 (9.52) | 29.6817 |
2010's | 1 (2.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barker, PB; Bryan, RN; Conturo, TE; Mathews, VP; Monsein, LH | 1 |
Higgins, CB; Saeed, M; Wendland, MF; Yu, KK | 1 |
Higgins, CB; Saeed, M; Wendland, MF | 2 |
Asgari, H; Kucharczyk, J; Mintorovitch, J; Moseley, M; Rocklage, S; Vexler, Z; Watson, A | 1 |
Asgari, HS; Derugin, N; Kucharczyk, J; Mintorovitch, J; Moseley, ME; Rocklage, S; Vexler, Z | 1 |
Higgins, CB; Saeed, M; Wendland, M | 1 |
Asgari, HS; Kucharczyk, J; Mintorovitch, J; Moseley, ME; Sevick, R; Wendland, MF; White, DL | 1 |
Asgari, H; Cohen, Y; Derugin, N; Kucharczyk, J; Kurhanewicz, J; Mintorovitch, J; Moseley, ME; Norman, D | 1 |
Kucharczyk, J; Moseley, ME; Norman, D; Quay, SC; Rocklage, SM | 1 |
Higgins, CB; Moseley, ME; Quay, SC; Rocklage, SM; Saeed, M; Tomei, E; Wendland, MF; Wolfe, C | 1 |
Nilsson, S | 1 |
Dae, MW; Derugin, N; Higgins, CB; Saeed, M; Velasquez-Rocha, S; Wendland, MF; Yu, KK | 1 |
Mühler, A | 1 |
Ericsson, A; Hemmingsson, A; Martinussen, HJ; Nilsson, S; Oksendal, AN; Waldenström, A; Wikström, G; Wikström, M | 1 |
Ericsson, A; Hemmingsson, A; Nilsson, S; Oksendal, A; Waldenström, A; Wikström, G; Wikström, M | 3 |
Dommisse, R; Lanens, D; Oksendal, A; Spanoghe, M; Van Audekerke, J; Van der Linden, A | 1 |
Bach-Gansmo, T; Ericsson, A; Hemmingsson, A; Niklasson, F | 1 |
Godtliebsen, F; Haraldseth, O; Jones, RA; Lindboe, CF; Müller, TB; Sebastiani, G; Unsgård, G | 1 |
Bleyl, K; Cox, I; Dillon, W; Harnish, P; Kucharczyk, J; Moseley, ME; Prayer, L; Roberts, TP | 1 |
Higgins, CB; Masui, T; Saeed, M; Wendland, MF | 1 |
Higgins, CB; Knollmann, F; Li, HT; Saeed, M; Wendland, MF | 1 |
Bleyl, KL; Dulce, MC; Higgins, CB; LaFrance, ND; Lucas, J; O'Sullivan, M; Saeed, M; Sakuma, H; Watson, A; Wendland, MF | 1 |
Haraldseth, O; Jones, RA; Müller, TB; Oksendal, AN; Rinck, PA | 1 |
Asgari, HS; Derugin, N; Kucharczyk, J; Mintorovitch, J; Moseley, ME; Roberts, TP; Vexler, ZS; Watson, AD | 1 |
de Crespigny, AJ; Kucharcyzk, J; Moseley, ME; Roberts, TP | 1 |
Ericsson, A; Hemmingsson, A; Martinussen, HJ; Waldenström, A; Wikström, G; Wikström, M | 1 |
Billups, KL; Choyke, PL; Costabile, RA; Desjardins, C; Diggs, R; Frank, JA; Girton, ME; Moonen, C | 1 |
Geschwind, JF; Higgins, CB; Saeed, M; Sakuma, H; Szolar, D; Wendland, M | 1 |
Delos, M; Demeure, R; Goudemant, JF; Jamart, J; Maldague, B; Oksendal, A; Pringot, J; Thiran, JP; Van Beers, BE | 1 |
Fahlvik, AK; Fossheim, S; Kellar, KE; Klaveness, J | 1 |
Derugin, N; Geschwind, JF; Higgins, CB; Lauerma, K; Saeed, M; Wendland, MF | 1 |
Bach-Gansmo, T; Dupas, B; Meflah, K; Muller, RN | 1 |
Arteaga, C; Canet, E; Forrat, R; Hadour, G; Oksendal, A; Revel, D; Zhao, S | 1 |
Higgins, CB; Lund, G; Saeed, M; Wendland, MF | 1 |
Bach-Gansmo, T; Buzelin, MF; Dupas, B; Karam, G; Meflah, K; Vasse, N | 1 |
Ahlström, H; Bjerner, T; Ericsson, A; Hemmingsson, A; Johansson, L | 1 |
Arteaga, C; Canet, E; Forrat, R; Hadour, G; Liu, S; Oksendal, A; Revel, D; Zhao, S | 1 |
Higgins, CB; Lee, RJ; Martin, AJ; Revel, D; Saeed, M; Saloner, D; Weber, O | 1 |
Canet-Soulas, E; Fossheim, SL; Fowler, RA; Lafon, C; Mestas, JL; Ngo, J | 1 |
2 review(s) available for sprodiamide and pentetic acid
Article | Year |
---|---|
Assessment of myocardial perfusion using contrast-enhanced MR imaging: current status and future developments.
Topics: Animals; Clinical Trials as Topic; Contrast Media; Coronary Circulation; Drug Combinations; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetics; Meglumine; Organometallic Compounds; Pentetic Acid; Perfusion; Rats | 1995 |
Contrast-enhanced MRI for quantification of myocardial viability.
Topics: Animals; Contrast Media; Dysprosium; Edetic Acid; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Myocardial Ischemia; Myocardial Stunning; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1999 |
1 trial(s) available for sprodiamide and pentetic acid
Article | Year |
---|---|
Sprodiamide-injection-enhanced magnetic resonance imaging of cerebral perfusion. Phase I clinical trial results.
Topics: Cerebrovascular Circulation; Contrast Media; Double-Blind Method; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1994 |
39 other study(ies) available for sprodiamide and pentetic acid
Article | Year |
---|---|
MR imaging of cerebral perfusion by phase-angle reconstruction of bolus paramagnetic-induced frequency shifts.
Topics: Animals; Brain; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Contrast Media; Dysprosium; Electron Spin Resonance Spectroscopy; Gadolinium; Gadolinium DTPA; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Microcirculation; Models, Biological; Models, Chemical; Models, Structural; Organometallic Compounds; Papio; Pentetic Acid; Putamen | 1992 |
Delineation of acute myocardial infarction with dysprosium DTPA-BMA: influence of dose of magnetic susceptibility contrast medium.
Topics: Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Female; Injections, Intravenous; Magnetic Resonance Spectroscopy; Muscles; Myocardial Infarction; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley; Signal Processing, Computer-Assisted; Time Factors | 1992 |
Strategies for differential enhancement of myocardial ischemia using echoplanar imaging.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Characterization of reperfused myocardial infarctions with T1-enhancing and magnetic susceptibility-enhancing contrast media.
Topics: Animals; Contrast Media; Diagnosis, Differential; Drug Evaluation, Preclinical; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA.
Topics: Animals; Brain; Cats; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Time Factors | 1991 |
Comparison of Gd- and Dy-chelates for T2 contrast-enhanced imaging.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1991 |
Contrast enhancement for the myocardium.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Myocardium; Organometallic Compounds; Pentetic Acid | 1991 |
Ultrafast magnetic resonance imaging: diffusion and perfusion.
Topics: Animals; Brain Ischemia; Cats; Cerebral Arteries; Cerebrovascular Disorders; Contrast Media; Diffusion; Dysprosium; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Perfusion; Time Factors | 1991 |
Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats.
Topics: Acute Disease; Animals; Brain; Brain Ischemia; Cats; Cerebrovascular Circulation; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Phosphorus; Protons | 1990 |
Early detection of perfusion deficits caused by regional cerebral ischemia in cats. T2-weighted magnetic susceptibility MRI using a nonionic dysprosium contrast agent.
Topics: Animals; Brain Ischemia; Cats; Contrast Media; Dysprosium; Magnetic Resonance Imaging; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Time Factors | 1990 |
Demarcation of myocardial ischemia: magnetic susceptibility effect of contrast medium in MR imaging.
Topics: Animals; Blood Pressure; Contrast Media; Coronary Disease; Dysprosium; Heart Rate; Magnetic Resonance Imaging; Muscles; Myocardium; Organometallic Compounds; Pentetic Acid; Radionuclide Imaging; Rats | 1989 |
MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Topics: Analysis of Variance; Animals; Contrast Media; Diagnosis, Differential; Dysprosium; Evaluation Studies as Topic; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors; Tissue Survival | 1995 |
Comparison of T1-enhancing and magnetic susceptibility magnetic resonance contrast agents for demarcation of the jeopardy area in experimental myocardial infarction.
Topics: Animals; Autoradiography; Contrast Media; Female; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardium; Observer Variation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley; Staining and Labeling; Tetrazolium Salts; Thallium Radioisotopes | 1993 |
Dy-DTPA-BMA as an indicator of tissue viability in MR imaging. An experimental study in the pig.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors; Tissue Survival | 1995 |
MR imaging of double-contrast enhanced porcine myocardial infarction. Correlation with microdialysis.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Drug Interactions; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Microdialysis; Myocardial Infarction; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors | 1995 |
Complementary use of T2-weighted and postcontrast T1- and T2*-weighted imaging to distinguish sites of reversible and irreversible brain damage in focal ischemic lesions in the rat brain.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Contrast Media; Dysprosium; Gadolinium; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar; Time Factors | 1995 |
Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging.
Topics: Cell Membrane; Contrast Media; Dysprosium; Erythrocytes; Gadolinium; Gadolinium DTPA; Hematocrit; Humans; Image Enhancement; In Vitro Techniques; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1995 |
Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Cerebrovascular Circulation; Contrast Media; Diffusion; Disease Models, Animal; Dysprosium; Frontal Lobe; Image Enhancement; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Organometallic Compounds; Parietal Lobe; Pentetic Acid; Perfusion; Putamen; Rats; Rats, Wistar; Reperfusion | 1995 |
Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media.
Topics: Animals; Contrast Media; Female; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1994 |
Comparison of cardiovascular response to ionic and nonionic magnetic resonance susceptibility contrast agents.
Topics: Animals; Contrast Media; Female; Hemodynamics; Magnetic Resonance Imaging; Male; Meglumine; Myocardial Infarction; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Rats; Rats, Sprague-Dawley; Time Factors | 1994 |
Effect of magnetic susceptibility contrast medium on myocardial signal intensity with fast gradient-recalled echo and spin-echo MR imaging: initial experience in humans.
Topics: Adult; Contrast Media; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1994 |
K-space substitution: a novel dynamic imaging technique.
Topics: Animals; Brain; Brain Ischemia; Contrast Media; Dysprosium; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Rats | 1993 |
Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia.
Topics: Acute Disease; Animals; Brain; Brain Ischemia; Cats; Cerebrovascular Circulation; Contrast Media; Echo-Planar Imaging; Gadolinium DTPA; Organometallic Compounds; Pentetic Acid | 1993 |
Improved sensitivity to magnetic susceptibility contrast.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Dysprosium; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Subtraction Technique | 1993 |
Double-contrast enhanced MR imaging of myocardial infarction in the pig.
Topics: Animals; Contrast Media; Female; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardium; Organometallic Compounds; Pentetic Acid; Swine | 1993 |
Dynamic enhanced magnetic resonance imaging of testicular perfusion in the rat.
Topics: Animals; Contrast Media; Ischemia; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley; Spermatic Cord Torsion; Testis | 1993 |
Myocardial cell death in reperfused and nonreperfused myocardial infarctions. MR imaging with dysprosioum-DTPA-BMA in the pig.
Topics: Animals; Cell Death; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Magnetic Resonance Angiography; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine | 1996 |
Double-contrast MR imaging of reperfused porcine myocardial infarction. An experimental study using Gd-DTAA and Dy-DTPA-BMA.
Topics: Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Angiography; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine | 1996 |
Identification of regional myocardial ischemia using contrast-enhanced dynamic magnetic resonance imaging in an experimental canine model of hemodynamically significant coronary arterial stenosis.
Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dogs; Gadolinium DTPA; Hemodynamics; Magnetic Resonance Imaging, Cine; Myocardial Infarction; Organometallic Compounds; Pentetic Acid; Regional Blood Flow | 1996 |
Detection of reperfused ischemia of the rat intestine: value of magnetic resonance imaging with small-molecular-weight dysprosium and gadolinium chelates.
Topics: Animals; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Image Enhancement; Injections, Intravenous; Intestines; Ischemia; Magnetic Resonance Imaging; Male; Molecular Weight; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar | 1997 |
Low-molecular weight lanthanide contrast agents: evaluation of susceptibility and dipolar effects in red blood cell suspensions.
Topics: Contrast Media; Doppler Effect; Erythrocytes; Gadolinium DTPA; Hematocrit; Hemolysis; Magnetic Resonance Imaging; Models, Biological; Molecular Weight; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Suspensions | 1997 |
AUR Memorial Award. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging.
Topics: Animals; Awards and Prizes; Cell Death; Contrast Media; Drug Evaluation, Preclinical; Dysprosium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1994 |
Synergistic effects of relaxation and susceptibility in differentiation between compartmentalized and noncompartmentalized tissues.
Topics: Animals; Contrast Media; Gadolinium DTPA; Kidney; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats | 1998 |
Myocardial "low reflow" assessed by Dy-DTPA-BMA-enhanced first-pass MR imaging in a dog model.
Topics: Animals; Contrast Media; Coronary Circulation; Dogs; Dysprosium; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Organometallic Compounds; Pentetic Acid | 1999 |
Contrast-enhanced MR imaging of experimental acute tubular necrosis.
Topics: Animals; Contrast Media; Diagnosis, Differential; Drug Combinations; Dysprosium; Gadolinium DTPA; Injections, Intravenous; Kidney Medulla; Kidney Tubular Necrosis, Acute; Kidney Tubules; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred BN | 2001 |
Contrast agents in acute myocardial infarction.
Topics: Contrast Media; Coronary Disease; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Organometallic Compounds; Pentetic Acid | 2001 |
Magnetic susceptibility of Dy-DTPA-BMA to reperfused myocardial infarction in an excised dog heart model: evidence of viable myocardium.
Topics: Animals; Contrast Media; Dogs; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid | 2000 |
MR guidance of targeted injections into border and core of scarred myocardium in pigs.
Topics: Animals; Contrast Media; Image Enhancement; Injections; Magnetic Resonance Imaging; Meglumine; Myocardial Infarction; Organometallic Compounds; Pentetic Acid; Phantoms, Imaging; Swine | 2006 |
Non-invasive magnetic resonance imaging follow-up of sono-sensitive liposome tumor delivery and controlled release after high-intensity focused ultrasound.
Topics: Animals; Cell Line, Tumor; Contrast Media; Delayed-Action Preparations; Follow-Up Studies; Gadolinium DTPA; High-Intensity Focused Ultrasound Ablation; Liposomes; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Prostatic Neoplasms; Rats; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |